Shopping Cart
Remove All
Your shopping cart is currently empty
EU-103 is a humanized monoclonal antibody that targets V-Set And Immunoglobulin Domain Containing 4 (VSIG4), with a KD value range between 10^-7 and 10^-9. It disrupts the interaction between VSIG4 and CD8+ T cells, facilitating the transformation of M2 macrophages to M1 macrophages, inducing proliferation of CD8+ T cells, and promoting the secretion of pro-inflammatory cytokines, thereby inhibiting tumor growth. EU-103 shows potential for research in cancer treatment, including bladder cancer, breast cancer, and colon cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | EU-103 is a humanized monoclonal antibody that targets V-Set And Immunoglobulin Domain Containing 4 (VSIG4), with a KD value range between 10^-7 and 10^-9. It disrupts the interaction between VSIG4 and CD8+ T cells, facilitating the transformation of M2 macrophages to M1 macrophages, inducing proliferation of CD8+ T cells, and promoting the secretion of pro-inflammatory cytokines, thereby inhibiting tumor growth. EU-103 shows potential for research in cancer treatment, including bladder cancer, breast cancer, and colon cancer. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.